SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (898)10/21/1997 11:13:00 AM
From: tonyt  Respond to of 2173
 
LGND can't seem to get back above $17 (coincidence??), nor can it muster up any investor interest -- Vol only at 200k. Unless interest picks up, the price may drop.



To: tonyt who wrote (898)10/21/1997 12:38:00 PM
From: bob smith  Read Replies (1) | Respond to of 2173
 
I agree.. Wery disappointing, isn't it..?

I just sold my remaning shares of LGND that I bought early this year on Henry's hype.
At least I didn't loose any money, but went thru a lot of frustration sifting thru all this hype & bs to find anything of value..

Bob



To: tonyt who wrote (898)10/21/1997 1:46:00 PM
From: David Bogdanoff  Read Replies (1) | Respond to of 2173
 
Tonyt:

I've already gone through a bunch of your postings concerning LGND on this ALMN thread, not learning much about AMLN in the process. A thousand "thank you's " if you could shift this discussion over to the LGND thread.
David

PS: in case you are merely responding to other's posting, I would also
give a thousand "thank you's" if everybody kept to the subject of this thread.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News